OPSUMIT (Actelion Pharmaceuticals US, Inc.)


Welcome to the PulseAid listing for the OPSUMIT drug offered from Actelion Pharmaceuticals US, Inc.. This Endothelin Receptor Antagonist [EPC],Endothelin Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Actelion Pharmaceuticals US, Inc.
NON-PROPRIETARY NAME: macitentan
SUBSTANCE NAME: MACITENTAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Endothelin Receptor Antagonist [EPC],Endothelin Receptor Antagonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-11-04
END MARKETING DATE: 0000-00-00


OPSUMIT HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOPSUMIT from Actelion Pharmaceuticals US, Inc.
LABELER NAME: Actelion Pharmaceuticals US, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2013-11-04
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66215-501_be878637-a2c5-42ea-9924-fc868d1f1323
PRODUCT NDC: 66215-501
APPLICATION NUMBER: NDA204410

Other MACITENTAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actelion Pharmaceuticals US, Inc.OPSUMIT